Best of Women's Health Coverage

New survey data add to the evidence regarding the safe and effective route of administering both COVID-19 and flu vaccines simultaneously.

Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.

Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.

Data assessing Novo Nordisk’s investigational diabetes and obesity medication were presented at The Menopause Society's 2026 Annual Meeting.

A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.

Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.

Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.

With safety and efficacy profiles aligning with its brand-name formulation, this new patch could be key for women struggling with hormone therapy adherence.